Preventive probiotics and prebiotics are vital for sustaining optimal health and reducing the risk of future health issues. Probiotics help maintain microbial balance in the gut, preventing the overgrowth of harmful bacteria that can lead to digestive problems and infections. Regular consumption of probiotics has been linked to a reduced risk of developing gastrointestinal diseases, such as inflammatory bowel disease and irritable bowel syndrome. Prebiotics, by fostering the growth of beneficial gut bacteria, enhance immune function and promote overall digestive health. This combination offers a preventive strategy for managing chronic conditions, including metabolic disorders, cardiovascular disease, and autoimmune conditions, highlighting the long-term benefits of integrating probiotics and prebiotics into daily health routines.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India